Guggenheim Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $123
Spruce Biosciences, Inc SPRB
$52.36
▲ +7.38%
(+$3.60)
Open
$49.48
Prev Close
$48.76
Day Range
$49.48 – $52.90
52W Range
$4.77 – $240.00
Market Cap
$144.11M
Beta
3.37
EPS (TTM)
$-38.31
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-10-09 |
| Shares Out. | 2,750,000 |
| Website | sprucebio.com/ ↗ |
| Phone | 13026365400 |
Spruce Biosciences, Inc is a publicly traded company under the ticker symbol SPRB on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-06-01)